Yes, a narrow focus can significantly impact the development of treatments:
1. Limited Scope of Therapies: Targeted therapies developed with a narrow focus may only be effective for a subset of patients. For instance, treatments designed for specific genetic mutations may not work for patients without those mutations.
2. Resistance Development: Cancer cells can become resistant to narrowly focused treatments. A broader approach might help in developing combination therapies that can prevent or overcome resistance.
3. Side Effects and Comorbidities: Focusing narrowly on eliminating cancer cells might overlook the broader impact on a patient’s health, leading to severe side effects or exacerbating other conditions.
